Table 1

Patient characteristics

Characteristicsn=12
Median age (years)16
Female3 (25%)
Hospitalised7 (58%)
UC10 (83%)
CD2 (17%)
Number of previous failed tumour necrosis (TNF) blocker therapies
 18 (67%)
 24 (33%)
Most recent TNF blocker before vedolizumab
 Infliximab9 (75%)
 Adalimumab3 (25%)